K. H. Dötz et al.
FULL PAPER
THF (16 mL), as described for compound 3a. M.p. 958C (decomp); Rf
(Et2O/PE/CH3OH, 15:5:1); MS (70 eV, EI): m/z (%): 299 ([M] , 1.4), 240
0.42 (Et2O/PE/CH3OH, 15:5:1); MS (70 eV, EI): m/z (%): 431 ([M] , 0.6),
([M CO2CH3] , 100), 208 ([240 CH3OH], 1.0), 184 (10.0), 152 (2.8), 142
403 ([M CO] , 8.2), 375 ([M 2CO] , 2.4), 319 ([M 4CO] , 16.8), 291
(35.0), 126 (2.8), 114 (8.2), 82 (5.7), 71 (14.2); HR-MS: C15H25NO5: calcd
1
([M 5CO] , 100), 110 (94.1), 94 ([MeNH C Cr] , 81.5), 69 (24.3), 55
(77.3); HR-MS: C17H2152CrNO7 (M CO): calcd 403.0723; found 403.0725;
IR (PE): nÄ 2056, 1976, 1938, 1922 cm 1; [a]D 81.8 (c 0.592, Et2O);
C18H21CrNO8 (431.36): calcd C 50.12, H 4.91, N 3.25; found C 50.22, H 4.87,
299.1732; found 299.1741; IR (film): nÄ 1743 cm
;
1H NMR (500 MHz,
C6D6): d 1.20 ± 1.27 (m, 2H; C6H10), 1.54 ± 1.59 (m, 4H; C6H10), 1.63 ± 1.72
(m, 2H; C6H10), 1.83 ± 1.93 (m, 2H; C6H10), 2.11 (s, 3H; NCH3), 2.47 (pt,
2J6/6' 10.83, 3J6/5 10.83, 1H; H-6), 2.76 (dd, 2J6'/6 10.83, 3J6'/5 5.30, 1H;
1
3
N 3.07; H NMR (500 MHz, CD3COCD3): d 1.30 ± 1.37 (m, 1H; C6H10),
H-6'), 3.04 (d, J2/3 8.54, 1H; H-2), 3.17 (s, 3H; OCH3), 3.39 (s, 3H;
3
3
1.49 ± 1.72 (m, 8H; C6H10), 1.79 ± 1.82 (m, 1H; C6H10), 3.40 (s, 3H; OCH3),
CO2CH3), 3.58 (m, 1H; H-5), 4.27 (dd, J4/3 4.57, J4/5 3.87, 1H; H-4),
4.55 (dd, 3J3/2 8.54, 3J3/4 4.57, 1H; H-3); 13C NMR (125 MHz, C6D6): d
23.9, 24.2, 25.2, 35.7, 38.3 (5C, C6H10), 43.2 (1C, NCH3), 51.6 (1C, CO2CH3),
54.1 (1C, C-6), 55.9 (1C, OCH3), 70.9 (1C, C-2), 71.9 (1C, C-4), 74.4 (1C,
C-5), 76.2 (1C, C-3), 110.7 (1C, Cspiro), 172.0 (1C, C-1).
2
3
3.65 (dd, J5'/5 13.61, J5'/4 2.19, 1H; H-5'), 3.74 (m, 1H; H-4), 3.80 (dd,
2J5/5' 13.61, 3J5/4 6.46, 1H; H-5), 3.90 (s, 3H; NCH3), 4.43 (dd, 3J3/2 7.35,
3J3/4 3.08, 1H; H-3), 4.88 (d, J2/3 7.35, 1H; H-2); 13C NMR (125 MHz,
3
CD3COCD3): d 24.3, 24.7, 26.0, 34.5, 36.4 (5C, C6H10), 53.6 (1C, NCH3),
55.9 (1C, C-5), 58.2 (1C, OCH3), 72.2 (2C, C-3, C-4), 86.2 (1C, C-2), 110.3
(1C, Cspiro), 219.1 (4C, COcis), 225.0 (1C, COtrans), 264.7 (1C, C-1).
Methyl 2,6-dideoxy-3,4-O-isopropylidene-5-O-methyl-2,6-(methylimino)-
d-allonate (17a): As in the general procedure above, compound 16a
(274 mg, 0.70 mmol) was irradiated in solution in methanol (12 mL). After
oxidation and chromatographic purification (eluent Et2O/PE/CH3OH,
15:5:3), 17a was obtained as a colorless syrup (0.49 mmol, 127 mg, 70%).
Pentacarbonyl[1,5-dideoxy-2,3-O-isopropylidene-4-O-methyl-1,5-(methyl-
imino)-d-ribo-pyranosylidene]chromium
(16a):
Compound
16a
(4.32 mmol, 1.69 g, 72%) was isolated as a yellow solid by reaction of
graphite (1.26 g, 105.6 mmol), potassium (516 mg, 13.2 mmol), and
Cr(CO)6 (1.45 g, 6.6 mmol) with 15a (1.29 g, 6.0 mmol) and TMSCl
(2.35 mL, 18.6 mmol) in THF (44 mL). M.p. 1108C (decomp); Rf 0.38
Rf 0.60 (Et2O/PE/CH3OH, 15:5:3); MS (70 eV, EI): m/z (%): 259 ([M] ,
2.4), 244 ([M CH3] , 4.7), 200 ([M CO2CH3] , 100), 184 ([244
HCO2CH3], 6.4), 142 ([200 Me2CO], 37.8), 114 (10.0), 100 (10.0), 82
(7.1), 71 (21.4); HR-MS: C12H21NO5: calcd 259.1419; found 259.1430; IR
(Et2O/PE/CH3OH, 15:5:1); MS (70 eV, EI): m/z (%): 391 ([M] , 1.7), 376
(film): nÄ 1745 cm 1; [a]D
7 (c 0.064, Et2O); C12H21NO5 (259.30):
([M CH3] , 0.3), 363 ([M CO] , 13.7), 335 ([M 2CO] , 2.7), 307
calcd C 55.58, H 8.16, N 5.40; found C 55.59, H 8.14, N 5.40; 1H NMR
(500 MHz, C6D6): d 1.26 (s, 3H; CH3), 1.56 (s, 3H; CH3), 2.11 (s, 3H;
NCH3), 2.46 (pt, 2J6/6' 10.72, 3J6/5 10.72, 1H; H-6), 2.72 (dd, 2J6'/6 10.72,
([M 3CO] , 1.0), 279 ([M 4CO] , 24.1), 251 ([M 5CO] , 100), 94
([H3CNH C Cr] , 51.6); HR-MS: C15H1752CrNO8: calcd 391.0359; found
391.0365; IR (PE): nÄ 2056, 1976, 1930 cm 1; [a]D 81.5 (c 0.404,
Et2O); C15H17CrNO8 (391.29): calcd C 46.04, H 4.38, N 3.58; found C 46.03,
H 4.39, N 3.40; 1H NMR (500 MHz, CD3OD): d 1.47 (s, 3H; CH3), 1.48 (s,
3H; CH3), 3.47 (s, 3H; OCH3), 3.58 (dd, 2J5/5' 13.71, 3J5/4 2.48, 1H; H-5),
3.69 (pquin, 1H; H-4), 3.76 (dd, 2J5'/5 13.71, 3J5'/4 6.65, 1H; H-5'), 3.93 (s,
3J6'/5 5.26, 1H; H-6'), 3.03 (d, J2/3 8.44, 1H; H-2), 3.15 (s, 3H; OCH3),
3
3
3
3
3.38 (s, 3H; CO2CH3), 3.49 (ddd, J5/6 10.72, J5/6' 5.26, J5/4 3.87, 1H;
H-5), 4.23 (dd, 3J4/3 4.67, 3J4/5 3.87, 1H; H-4), 4.51 (dd, 3J3/2 8.44, 3J3/4
4.67, 1H; H-3); 13C NMR (125 MHz, C6D6): d 26.3, 28.3 (2C, CH3), 43.3
(1C, NCH3), 51.6 (1C, CO2CH3), 54.2 (1C, C-6), 55.9 (1C, OCH3), 70.9
(1C, C-2), 72.2 (1C, C-4), 74.5 (1C, C-5), 76.8 (1C, C-3), 109.9 (1C, Me2C),
172.5 (1C, C-1).
3
3
3
3H; NCH3), 4.39 (dd, J3/2 7.55, J3/4 3.27, 1H; H-3), 4.94 (d, J2/3 7.55,
1H; H-2); 13C NMR (125 MHz, CD3OD): d 24.4, 26.1 (2C, CH3), 53.5
(1C, NCH3), 55.6 (1C, C-5), 58.2 (1C, OCH3), 72.7 (1C, C-3), 72.9 (1C,
C-4), 86.9 (1C, C-2), 110.1 (1C, Me2C), 219.6 (4C, COcis), 225.4 (1C,
COtrans), 266.9 (1C, C-1).
Methyl 5-O-benzyl-2,6-(benzylimino)-2,6-dideoxy-3,4-O-isopropylidene-
d-allonate (17b): As in the general procedure above, compound 16b
(380 mg, 0.70 mmol) was irradiated in solution in methanol (12 mL). After
oxidation and chromatographic purification (eluent Et2O/PE/CH3OH,
15:5:1) 17b was first obtained as a colorless syrup (0.42 mmol, 170 mg,
59%). Then compound 15b (56 mg) eluted as the product of oxidative
degradation. Rf 0.49 (Et2O/PE/CH3OH, 15:5:1); MS (70 eV, EI): m/z
Pentacarbonyl[4-O-benzyl-1,5-(benzylimino)-1,5-dideoxy-2,3-O-isopropyli-
dene-d-ribo-pyranosylidene]chromium (16b): Compound 16b (3.09 mmol,
1.68 g, 62%) was obtained as a sticky orange foam by reaction of graphite
(1.05 g, 88.0 mmol), potassium (430 mg, 11.0 mmol), and Cr(CO)6 (1.21 g,
5.5 mmol) with 15b (1.83 g, 5.0 mmol) and TMSCl (1.95 mL, 15.5 mmol) in
THF (35 mL), as described above for compound 3a. Rf 0.36 (Et2O/PE/
(%): 411 ([M] , 4.1), 396 ([M CH3] , 20.8), 352 ([M CO2CH3] , 85.0),
305 ([396 C7H7], 6.6), 294 ([352 Me2CO], 13.3), 91 ([C7H7] , 100); HR-
CH3OH, 15:10:1); MS (70 eV, EI): m/z (%): 459 ([M 3CO] , 3.3), 431
1
([M 4CO] , 0.8), 403 ([M 5CO] , 1.2), 388 (0.7), 345 ([403 Me2CO],
MS: C24H29NO5: calcd 411.2045; found 411.2048; IR (film): nÄ 1742 cm
;
1.8), 312 ([403 C7H7], 1.8), 293 ([345 Me2CO], 2.0), 276 (3.0), 170
[a]D 25.8 (c 0.062, Et2O); C24H29NO5 (411.49): calcd C 70.05, H 7.10,
N 3.40; found C 69.69, H 7.19, N 3.17; 1H NMR (500 MHz, C6D6/TMS): d
1.22 (s, 3H; CH3), 1.59 (s, 3H; CH3), 2.51 (dd, 2J6/6' 10.83, 3J6/5 10.53, 1H;
([BnNH C Cr] , 11.6), 91 ([C7H7] , 100); HR-MS: C24H2552CrNO5 (M
1
3CO): calcd 459.1137; found 459.1136; IR (PE): 2056, 1977, 1934 cm
;
1H NMR (500 MHz, CD3COCD3): d 1.46 (s, 3H; CH3), 1.51 (s, 3H; CH3),
2
3
2
H-6), 2.95 (dd, J6'/6 10.83, J6'/5 5.26, 1H; H-6'), 3.14 (d, J 13.11, 1H;
2
3
2
3
3
3.40 (dd, J5'/5 14.27, J5'/4 1.94, 1H; H-5'), 3.68 (dd, J5/5' 14.27, J5/4
PhCH2), 3.31 (s, 3H; OCH3), 3.38 (d, J2/3 7.85, 1H; H-2), 3.63 (ddd,
3
3
3J5/6 10.53, J5/6' 5.26, J5/4 3.87, 1H; H-5), 3.76 (d, 2J 13.11, 1H;
3
3
5.31, 1H; H-5), 3.95 (m, 1H; H-4), 4.45 (dd, J3/2 8.09, J3/4 4.57, 1H;
H-3), 4.46 (d, 2J 12.16, 1H; PhCH2), 4.71 (d, 2J 12.16, 1H; PhCH2), 5.07
3
3
PhCH2), 4.19 (d, 2J 11.82, 1H; PhCH2), 4.25 (dd, J4/3 4.87, J4/5 3.87,
1H; H-4), 4.32 (d, 2J 11.82, 1H; PhCH2), 4.53 (dd, 3J3/2 7.85, 3J3/4 4.87,
1H; H-3), 7.03 ± 7.33 (m, 10H; H-aryl); 13C NMR (125 MHz, C6D6/TMS):
d 26.2, 28.3 (2C, CH3), 50.1 (1C, C-6), 51.6 (1C, CO2CH3), 59.7 (1C,
PhCH2), 69.5 (1C, C-2), 70.7 (1C, PhCH2), 73.0 (1C, C-5), 73.2 (1C, C-4),
77.0 (1C, C-3), 110.1 (1C, Me2C), 127.5, 127.6, 128.3, 128.4, 128.5, 129.3
(10C, aryl-C), 138.4, 138.8 (2C, Cipso), 172.7 (1C, C-1).
3
(d, J2/3 8.09, 1H; H-2), 5.53 (d, 2J 14.70, 1H; PhCH2), 5.58 (d, 2J
14.70, 1H; PhCH2), 7.23 ± 7.33 (m, 8H; H-aryl), 7.39 ± 7.42 (m, 2H; H-aryl);
13C NMR (125 MHz, CD3COCD3): d 24.2, 26.0 (2C, CH3), 54.2 (1C, C-5),
68.8 (1C, PhCH2), 70.1 (1C, C-4), 72.4 (1C, PhCH2), 72.9 (1C, C-3), 86.5
(1C, C-2), 109.5 (1C, Me2C), 127.8, 128.1, 128.9, 129.0, 129.1, 129.5 (10C,
aryl-C), 134.9, 139.5 (2C, Cipso), 218.7 (4C, COcis), 224.9 (1C, COtrans), 267.5
(1C, C-1).
(6'-Deoxy-1',2':3',4'-di-O-isopropylidene-a-d-galactopyranos-6'-yl)-2,6-di-
deoxy-3,4-O-isopropylidene-5-O-methyl-2,6-(methylimino)-d-allonate
(19): A solution of 16a (274 mg, 0.70 mmol) and 1,2:3,4-di-O-isopropyli-
dene-a-d-galactopyranose 18[23] (200 mg, 0.77 mmol) in THF (6 mL) was
irradiated for five days. Oxidative workup of the reaction residue in Et2O/
PE (1:1, 40 mL) in air and subsequent chromatographic purification (eluent
Et2O/PE/CH3OH, 15:5:1) give first unconverted starting material 18
(127 mg), followed by the disaccharide 19 as a colorless syrup (0.18 mmol,
88 mg, 25%), and then the lactam 15a (83 mg). Rf 0.30 (Et2O/PE/
General procedure for the photoinduced generation of the methyl 2,6-
imino-d-allonates 10 and 17a,b: Carbene complex 9 or 16a,b and methanol
were loaded into a flame-dried Schlenk tube. The resulting solution (under
argon) was irradiated with a 125 W high-pressure mercury lamp at 258C for
five days. The solvent was evaporated and the residue was taken up in
Et2O/PE (1:1, 40 mL). Unconverted carbene complex and chromium
precipitates were oxidized by vigorous stirring in air. After filtration of the
solids and evaporation of the solvent, the crude product was purified by
column chromatography.
CH3OH, 15:5:1); MS (70 eV, EI): m/z (%): 487 ([M] , 0.8), 472 ([M
Methyl 3,4-O-cyclohexylidene-2,6-dideoxy-5-O-methyl-2,6-(methylimino)-
d-allonate (10): As in the general procedure above, compound 9 (164 mg,
0.38 mmol) was irradiated in solution in methanol (9 mL). After oxidation
and chromatographic purification (eluent Et2O/PE/CH3OH, 15:5:1), 10
was obtained as a colorless syrup (0.14 mmol, 43 mg, 38%). Rf 0.32
CH3] , 7.8), 414 ([472 Me2CO], 1.5), 245 (2.0), 200 (100), 142 ([200
Me2CO], 16.1); HR-MS: C23H37NO10: calcd 487.2417; found 487.2414;
[a]D
21.3 (c 0.052, Et2O); C23H37NO10 (487.54): calcd C 56.66, H 7.65,
N 2.87; found C 56.37, H 7.56, N 2.68; 1H NMR (500 MHz, C6D6): d 1.02
(s, 3H; CH3gal), 1.10 (s, 3H; CH3gal), 1.24 (s, 3H; CH3all), 1.39 (s, 3H; CH3gal),
698
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 1999
0947-6539/99/0502-0698 $ 17.50+.50/0
Chem. Eur. J. 1999, 5, No. 2